Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1994-04-25
1995-11-07
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424490, 424491, 424494, 424498, 424450, 514832, A61K 916, A61K 918, A61K 3842
Patent
active
054646340
ABSTRACT:
A red blood cell surrogate which is composed of a nanocrystalline core particle to which an oxygen carrier such as hemoglobin is bound. An oxygen carrier anchor coating is provided between the nanocrystalline core particle and the oxygen carrier in order to provide binding of the oxygen carrier to the nanocrystalline core particle without denaturing the oxygen carrier or otherwise destroying its oxygen carrying capacity. The nanocrystalline core particle with the oxygen carrier bound thereto is coated with a layer of lipid and then an outer layer of a sugar or allosteric effector is applied.
REFERENCES:
patent: 5306508 (1994-04-01), Kossovsky et al.
Loo et al., "Alkaloid Formation in Ergot Sclerotia," Science, vol. 121, Mar. 1955, pp. 367-369.
Lewis, R. W., "Artificial Inoculation of Rye with Ergot. A Susceptible Rye and the Control of Ergot Beetles," J. Am. Pharm. Assoc., Dec. 1948, pp. 511-512.
von Recum, A. F., "Ceramics," Handbook of Biomaterials Evaluation, 1986, pp. 38-54.
Gelman Andrew E.
Hnatyszyn H. James
Kossovsky Nir
Page Thurman K.
Spear James M.
The Regents of the University of California
LandOfFree
Red blood cell surrogate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Red blood cell surrogate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Red blood cell surrogate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-195812